BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Stem Cell Therapeutics 

1520 4th Street SW, Suite 1000

Calgary  Alberta  T2R 1H5  Canada
Phone: 403-245-5495 Fax: 403-245-5411


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Stem Cell Therapeutics (SSS.V) Wraps Up $33 Million Financing Round 12/16/2013 7:22:11 AM    More...
Stem Cell Therapeutics (SSS.V) Reorganizes, Names New Management Team 12/7/2011 8:11:09 AM    More...
Stem Cell Therapeutics (SSS.V) Announces Outcome of End of Phase II Meeting With FDA and Provides a Corporate Update & 2011/12 Milestones 12/27/2010 8:52:56 AM    More...
Stem Cell Therapeutics (SSS.V) Announces the Issuance of United States Patent Relating to NTx(R)-265 12/9/2010 10:25:58 AM    More...
Executive Changes at Stem Cell Therapeutics (SSS.V); Alan Moore Will No Longer Be President and CEO and Allen Davidoff Will Become Chief Scientific Officer 11/30/2010 8:13:48 AM    More...
Stem Cell Therapeutics (SSS.V) Announces Proceeds From Execution of Warrants 11/3/2010 8:39:27 AM    More...
Stem Cell Therapeutics (SSS.V) Receives Request for Full TBI Proposal From the US Dept of Defense 10/13/2010 9:34:06 AM    More...
Stem Cell Therapeutics (SSS.V) Receives FDA End of Phase II Meeting Date 10/8/2010 9:11:58 AM    More...
Stem Cell Therapeutics (SSS.V) Announces Appointment of Chief Financial Officer 10/1/2010 8:41:25 AM    More...
Stem Cell Therapeutics (SSS.V) Announces the Resignation of a Board of Director 9/15/2010 11:57:38 AM    More...
12345678910...